The Abu Dhabi Cardiovascular Program: the continuation of Framingham

Area of Science:

• Public Health
• Epidemiology
• Cardiovascular Medicine

Background:

• The Framingham study significantly advanced cardiovascular disease (CVD) risk identification globally.
• Effective, scalable population-level interventions are crucial for 21st-century public health.
• Adapting CVD prevention strategies to diverse economic settings remains a key challenge.

Observation:

• The Abu Dhabi Cardiovascular Program, "Weqaya," has provided a Framingham Risk Score to almost every adult Emirati within two years.
• The program integrates health sector innovations (mobile clinics, patient experience focus) with societal approaches (policy, regulation, individual empowerment).
• Central coordination, routine monitoring, and simple metrics are vital for the program's success.

Findings:

• Abu Dhabi's approach establishes a robust platform for scalable CVD interventions and continuous learning.
• Unique regional data architecture will facilitate the development of a localized CVD risk score, incorporating novel factors.
• Significant progress in CVD management has been achieved, with future potential for large-scale solutions.

Implications:

• The Abu Dhabi model demonstrates scalability and adaptability for low- and middle-income countries facing high CVD burdens.
• Urgent, evidence-based public health actions are necessary to combat the global CVD crisis.
• This initiative provides a replicable framework for proactive cardiovascular health management worldwide.